Lefamulin: Review of a Promising Novel Pleuromutilin Antibiotic-Reference-Cited by-同舟云学术

Lefamulin: Review of a Promising Novel Pleuromutilin Antibiotic

Published:2018-08-20 Issue:9 Volume:38 Page:935-946
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Veve Michael P.¹^ORCID,Wagner Jamie L.²^ORCID

Affiliation:

1. Department of Clinical Pharmacy and Translational Science; University of Tennessee Health Science Center; Knoxville Tennessee

2. Department of Pharmacy Practice; University of Mississippi; Jackson Mississippi

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/phar.2166/fullpdf

Reference60 articles.

1. Novel approaches are needed to develop tomorrow's antibacterial therapies;Spellberg;Am J Respir Crit Care Med,2015

2. Where are all the new antibiotics? The new antibiotic paradox;Conly;Can J Infect Dis Med Microbiol,2005

3. The 10 × ′20 initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020;The Infectious Diseases Society of America;Clin Infect Dis,2010

4. Antibiotics in late clinical development;Fernandes;Biochem Pharmacol,2017

5. Antibiotics currently in global clinical development 2018 http://www.pewtrusts.org/en/multimedia/data-visualizations/2014/antibiotics-currently-in-clinical-development

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanozymes and their biomolecular conjugates as next-generation antibacterial agents: A comprehensive review;International Journal of Biological Macromolecules;2024-10

2. Advances in polymeric and non-polymeric nanocarriers for the magnified delivery of levofloxacin against bacterial infection;Journal of Nanoparticle Research;2024-08

3. Treatment of MRSA Infection: Where are We?;Current Medicinal Chemistry;2024-08

4. Ameliorating Gonorrhea: Recent Therapeutic Adaptations and Scope to Improve its Prevailing Condition;Infectious Disorders - Drug Targets;2024-08

5. An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023);Journal of Medicinal Chemistry;2024-07-12